This site is intended for Healthcare Professionals only

Incorrect username and/or password, please try again or click to reset.

Class 3 Medicines Recall: Lynparza capsule 50mg (olaparib)

2018-03-12 11:47:49 (8 year(s) ago)

Summary

AstraZeneca is recalling batch NG327 as the level of olaparib polymorphic form L exceeds the registered specification limit.

Read full MHRA article

Respond to this alert

Sign up for your FREE ticket to see PharmData at the Pharmacy Show to see our latest products and features demonstrated live!